Tuesday, September 30, 2014

Traveler from Liberia is first Ebola patient diagnosed in U.S.



© Getty Images Ebola virus
 (Reuters) - A man who flew from Liberia to Texas has become the first patient infected with the deadly Ebola virus to be diagnosed in the United States, health officials said on Tuesday, a sign the outbreak ravaging West Africa may spread globally.
The patient sought treatment six days after arriving in Texas on Sept. 20, Dr. Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention (CDC), told reporters. He was admitted two days later to an isolation room at Texas Health Presbyterian Hospital in Dallas.
U.S. health officials and lawmakers have been bracing for the eventuality that a patient would arrive on U.S. shores undetected, testing the preparedness of the nation's healthcare system. On Tuesday, Frieden and other health authorities said they were taking every step possible to ensure the virus did not spread widely.
"It is certainly possible someone who had contact with this individual could develop Ebola in the coming weeks," Frieden told a news conference. "I have no doubt we will stop this in its tracks in the United States."
Frieden said a handful of people, mostly family members, may have been exposed to the patient after he fell ill and that health authorities were tracking down anyone who might have had contact with the man. The emergency responders who transported the man to the hospital have been quarantined, according to a statement from Dallas city officials.
He said there was likely no threat to any airline passengers because the patient had no symptoms during his flight. Asked whether the patient was a U.S. citizen, Frieden described the person as a visitor to family in the country.

At least 3,091 people have died from Ebola in the worst outbreak on record that has been ravaging Liberia, Sierra Leone and Guinea in West Africa. More than 6,500 cases have been diagnosed, and the CDC has warned that the number of infections could rise to as many as 1.4 million people by early next year without a massive global intervention to contain the virus.


Dire Warnings by Big Tobacco on E-Smoking


Tobacco companies, long considered public health enemy No. 1, have suddenly positioned themselves as protectors of consumer well-being in the digital age.
They are putting out among the strongest health warnings in the fledgling e-cigarette industry, going further even than the familiar ones on actual cigarettes, a leading cause of death. It has left the industry’s critics scratching their heads and deeply skeptical.
...
Experts with years studying tobacco company behavior say they strongly suspect several motives, but, chiefly, that the e-cigarette warnings are a very low-risk way for the companies to insulate themselves from future lawsuits and, even more broadly, to appear responsible, open and frank. By doing so, the experts said, big tobacco curries favor with consumers and regulators, earning a kind of legitimacy that they crave and have sought for decades. Plus, they get to appear more responsible than the smaller e-cigarette companies that seek to unseat them.
The reason the strategy is low risk, experts said, is that many people don’t read the warnings anyway.
More


Breast Cancer Drug Perjeta Appears to Greatly Extend Patients’ Lives




Photo
Patients in a trial who received Perjeta, from Roche, had a median survival time much longer than those in the control group.CreditRoche
Continue reading the main storyShare This Page

A drug used to treat advanced breast cancer has had what appears to be unprecedented success in prolonging lives in a clinical trial, researchers reported on Sunday.
Patients who received the drug — Perjeta, from the Swiss drug maker Roche — had a median survival time nearly 16 months longer than those in the control group.
That is the longest amount of time for a drug used as an initial treatment for metastatic breast cancer, the researchers said, and it may be one of the longest for the treatment of any cancer.
Most cancer drugs prolong survival in patients with metastatic disease for a few months at most. Metastasis means the cancer has spread to other parts of the body.
“We’ve never seen anything like this before,” said Dr. Sandra M. Swain of the MedStar Washington Hospital Center in Washington, the lead author of the study. “It’s really unprecedented to have this survival benefit.”

More


Thursday, September 25, 2014

Dying brain cells cue new brain cells to grow in songbird


Additional neurons make the part of the sparrow's brain that produces its song about twice as large during the breeding season, depicted here in red, compared to its size the rest of the year, shown in green.
Credit: G Bentley/E Brenowitz/U of Washington
Brain cells that multiply to help birds sing their best during breeding season are known to die back naturally later in the year. For the first time researchers have described the series of events that cues new neuron growth each spring, and it all appears to start with a signal from the expiring cells the previous fall that primes the brain to start producing stem cells.
If scientists can further tap into the process and understand how those signals work, it might lead to ways to exploit these signals and encourage replacement of cells in human brains that have lost neurons naturally because of aging, severe depression or Alzheimer's disease, said Tracy Larson, a University of Washington doctoral student in biology. She's lead author of a paper in the Sept. 23 Journal of Neuroscience on brain cell birth that follows natural brain cell death.
Neuroscientists have long known that new neurons are generated in the adult brains of many animals, but the birth of new neurons - or neurogenesis - appears to be limited in mammals and humans, especially where new neurons are generated after there's been a blow to the head, stroke or some other physical loss of brain cells, Larson said. That process, referred to as "regenerative" neurogenesis, has been studied in mammals since the 1990s.
This is the first published study to examine the brain's ability to replace cells that have been lost naturally, Larson said.
"Many neurodegenerative disorders are not injury-induced," the co-authors write, "so it is critical to determine if and how reactive neurogenesis occurs under non-injury-induced neurodegenerative conditions."
The researchers worked with Gambel's white-crowned sparrows, a medium-sized species 7 inches (18 centimeters) long that breeds in Alaska, then winters in California and Mexico. Sometimes in flocks of more than 100 birds, they can be so plentiful in parts of California that they are considered pests. The ones in this work came from Eastern Washington.
Like most songbirds, Gambel's white-crowned sparrows experience growth in the area of the brain that controls song output during the breeding season when a superior song helps them attract mates and define their territories. At the end of the season, probably because having extra cells exacts a toll in terms of energy and steroids they require, the cells begin dying naturally and the bird's song degrades.
Gambel's white-crowned sparrows are particularly good to work with because their breeding cycle is closely tied to the amount of sunlight they receive. Give them 20 hours of light in the lab, along with the right increase of steroids, and they are ready to breed. Cut the light to eight to 12 hours and taper the steroids, the breeding behavior ends.
"As the hormone levels decrease, the cells in the part of the brain controlling song no longer have the signal to 'stay alive,'" Larson said. "Those cells undergo programmed cell death - or cell suicide as some call it. As those cells die it is likely they are releasing some kind of signal that somehow gets transmitted to the stem cells that reside in the brain. Whatever that signal is then triggers those cells to divide and replace the loss of the cell that sent the signal to begin with."
The next spring, all that's needed is for steroids to ramp up and new cells start to proliferate in the song center of the brain.
"This paper doesn't describe the exact nature of the signals that stimulate proliferation," Larson said. "We're just describing the phenomenon that there is this connection between cells dying and this stem cell proliferation. Finding the signal is the next step."
"Tracy really nailed this down by going in and blocking cell death at the end of the breeding season," said Eliot Brenowitz, UW professor of psychology and of biology, and co-author on the paper. "There are chemicals you can use to turn off the cell suicide pathway. When this was done, far fewer stem cells divided. You don't get that big uptick in new neurons being born. That's important because it shows there's something about the cells dying that turns on the replacement process.'
"There's no reason to think what goes on in a bird brain doesn't also go on in mammal brains, in human brains," Brenowitz says. "As far as we know, the molecules are the same, the pathways are the same, the hormones are the same. That's the ultimate purpose of all this, to identify these molecular mechanisms that will be of use in repairing human brains."
In mammals, the area of the brain that controls the sense of smell and the one that is thought to have a role in memories can produce tiny numbers of new brain cells but it is not understood how or why. The numbers of new cells is so low that trying to identify and quantify if dying cells are being replaced and if so, the steps that are involved, is much more difficult than when using a songbird like Gambel's white-crowned sparrow, Larson and Brenowitz said.
The other co-authors on the paper are Nivretta Thatra, who started working with Larson while still in high school, continued while earning her UW undergraduate degree and is now at the Allen Institute for Brain Science; and Brian Lee, who worked in Brenowitz's UW lab while earning his undergraduate degree from Johns Hopkins University. The work was supported by the National Institutes of Health and the UW Department of Biology.

Soda Producers Set Goals on Cutting U.S. Beverage Calories

The Wall Street Journal

Companies Pledge to Market Water, Smaller Sizes, Diet Drinks; Pledge 20% Calorie Cut by 2025

Smaller containers, such as these mini cans, shown next to full-size cans, would be part of the calorie-cutting effort, as would heavier promotion of low-cal drinks. 
Coca-Cola Co. KO -1.16% , PepsiCo Inc. PEP -0.89% and Dr Pepper Snapple GroupInc. DPS -1.52% will work to cut beverage calories in the American diet 20% by 2025 through promoting bottled water, low-calorie drinks and smaller portions.
The pledge marks a rare commitment by beverage makers in the fight against obesity at a time when the industry is under increasing scrutiny of its products. Drink-makers opposed a cap on sugary drink portions in New York City, and are trying to stop a new tax on sugary drinks that San Francisco residents will vote on in November.
Under the voluntary agreement announced Tuesday, the companies said they would market and distribute their drinks in a way that should help steer consumers to smaller portions and zero- or low-calorie drinks. They also have committed to providing calorie counts on more than 3 million vending machines, self-serve fountain dispensers and retail coolers in stores, restaurants and other points of sale.
Americans already have scaled back on soda as consumers get more health conscious about diseases like diabetes, eroding the industry's bottom line. U.S. per capita soda consumption has fallen since peaking in 1998 and calories from soda contracted 23% between 2000 and 2013, industry tracker Beverage Digest estimates.
The move is an implicit acknowledgment by the soda industry that longtime staples like Coke, Pepsi-Cola and Dr Pepper have played a role in rising obesity rates.
Atlanta-based Coke has said in the past that Americans should exercise more, not drink less sugary soda.

Wednesday, September 24, 2014

The key to better biofuels could be in your gut

Scientists are on the hunt for microbes that can turn plant material into simple sugars, which can in turn be fed to yeast to produce ethanol --  a low emission, renewable fuel.
According to a study published in the Proceedings of the National Academy of Sciences, a pair of bacteria found in the human stomach might be especially adept at the task.
Lead researcher Isaac Cann, a professor of genomic biology at the University of Illinois, was looking at microbes in cows when he made the leap. "In looking for biofuels microbes in the cow rumen, we found that Prevotella bryantii, a bacterium that is known to efficiently break down (the plant fiber) hemicellulose, gears up production of one gene more than others when it is digesting plant matter," Cann said in a statement.
But when he and his team searched for genes similar to that one across the animal kingdom, human gut microbes popped up.
As it turns out, the two bacteria (Bacteroides intestinalis and Bacteroides ovatus), which are related to the species found in cows, are actually better at breaking down plant fibers.
Cann and his team are still working on confirming just how the microbes break down fiber into simple sugar -- and whether or not the bugs in our tummies could really contribute to biofuel production.

Washington Post:
http://www.washingtonpost.com/news/speaking-of-science/wp/2014/09/23/the-key-to-better-biofuels-could-be-in-your-gut/

Tuesday, September 23, 2014

Health Agency’s New Assessment of the Epidemic Is More Dire Still

New figures published Monday by the World Health Organization reveal a far worse outlook than it had previously anticipated for the Ebola epidemic in West Africa.
In addition to predicting many more cases and deaths, the new report for the first time raises the possibility that the epidemic will not be brought under control and that the disease will become endemic in West Africa, meaning that it could reach a steady state and become a constant presence there.
“The epidemiologic outlook is bleak,” the report said.
If control does not improve now, there will be more than 20,000 cases by Nov. 2, and the numbers of cases and deaths will continue increasing from hundreds to thousands per week for months to come, according to the report. The death rate is about 70 percent in each of the heavily affected countries, Guinea, Liberia and Sierra Leone.
The new estimates were published online in The New England Journal of Medicine by a team of more than 50 scientists. An earlier prediction by the health organization was far less dire, saying there might be 20,000 cases in nine months.
More
NEJM Editorial
the current epidemiologic outlook is bleak. Forward projections suggest that unless control measures — including improvements in contact tracing, adequate case isolation, increased capacity for clinical management, safe burials, greater community engagement, and support from international partners — improve quickly, these three countries will soon be reporting thousands of cases and deaths each week

Ebola Cases Could Reach 1.4 Million in 4 Months, C.D.C. Estimates

Yet another set of ominous projections about the Ebola epidemic in West Africa was released Tuesday, in a report from the Centers for Disease Control and Prevention that gave worst- and best-case estimates for Liberia and Sierra Leone based on computer modeling.
In the worst-case scenario, Liberia and Sierra Leone could have 21,000 cases of Ebola by Sept. 30 and 1.4 million cases by Jan. 20 if the disease keeps following its current trajectory, without effective methods to contain it. These figures take into account the fact that many cases go undetected, and estimate that there are actually 2.5 times as many as reported.
In the best-case model — which assumes that the dead are buried safely and that 70 percent of patients are treated in settings that reduce the risk of transmission — the epidemic in both countries would be “almost ended” by Jan. 20, the report said.
More

Fresh Graves Point to Undercount of Ebola Toll



Saturday, September 20, 2014

Scientists splice plants with bacteria to supercharge their growth

You don't need to be a farmer to know that weeds grow faster than potatoes. But scientists have been trying for a while to make slow-growing plants -- like wheat and rice -- perform more like fast crops, like corn and many weeds. The key is the way the crops photosynthesize, and some genetic splicing could trick slow plants into speeding up.

In a new study published in Nature, scientists borrowed genes fromphotosynthesizing bacteria -- which are quicker and more efficient at the process than many plants -- and grafted them into tobacco crops. So far, the researchers have only pushed the tobacco plants through two steps of the bacteria's three-part photosynthesis process. From MIT Technology Review:
First, proteins form a special compartment within a plant cell that concentrates CO2; second, the compartment contains a speedy enzyme for converting that CO2; and third, the cells use special pumps in their membranes to usher CO2 into the cells.
Earlier this year, the researchers engineered cells to form the special CO2 compartments. The new research takes care of the second part—the speedy enzyme. They’re collaborating with other researchers on the third part, the pumps. Ultimately the researchers will need to put all three parts together in the same plants.
In fact, PopularMechanics reports, the genetically engineered tobacco in this experiment actually grew more slowly than natural plants, because it only produced the special enzyme -- without those compartments or pumps. To make it grow faster, the researchers need to combine all three steps.
For this reason, commercial crops grown with these alterations are probably at least a decade off. But eventually, the researchers say, these changes could boost crop yields by as much as 60 percent for some plants -- and allow farmers to use less water and fertilizer in the process.
Washington Post:
http://www.washingtonpost.com/news/speaking-of-science/wp/2014/09/18/scientists-splice-plants-with-bacteria-to-supercharge-their-growth/

Friday, September 19, 2014

Could Fighting Global Warming Be Cheap and Free?

This just in: Saving the planet would be cheap; it might even be free. But will anyone believe the good news?
I’ve just been reading two new reports on the economics of fighting climate change: a big study by a blue-ribbon international group, the New Climate Economy Project, and a working paperfrom the International Monetary Fund. Both claim that strong measures to limit carbon emissions would have hardly any negative effect on economic growth, and might actually lead to faster growth. This may sound too good to be true, but it isn’t. These are serious, careful analyses.
But you know that such assessments will be met with claims that it’s impossible to break the link between economic growth and ever-rising emissions of greenhouse gases, a position I think of as “climate despair.” The most dangerous proponents of climate despair are on the anti-environmentalist right. But they receive aid and comfort from other groups, including some on the left, who have their own reasons for getting it wrong.
More

Artificial Sweeteners May Disrupt Body’s Blood Sugar Controls


Sweeteners alter the microbiome, the population of bacteria that is in the digestive system.

Credit Weizmann Institute of Science
Artificial sweeteners may disrupt the body’s ability to regulate blood sugar, causing metabolic changes that can be a precursor to diabetes, researchers are reporting.
That is “the very same condition that we often aim to prevent” by consuming sweeteners instead of sugar, said Dr. Eran Elinav, an immunologist at the Weizmann Institute of Science in Israel, at a news conference to discuss the findings.
The scientists performed a multitude of experiments, mostly on mice, to back up their assertion that the sweeteners alter the microbiome, the population of bacteria that is in the digestive system.
The different mix of microbes, the researchers contend, changes the metabolism of glucose, causing levels to rise higher after eating and to decline more slowly than they otherwise would.
...
In the initial set of experiments, the scientists added saccharin (the sweetener in the pink packets of Sweet’N Low), sucralose (the yellow packets of Splenda) or aspartame (the blue packets of Equal) to the drinking water of 10-week-old mice. Other mice drank plain water or water supplemented with glucose or with ordinary table sugar. After a week, there was little change in the mice who drank water or sugar water, but the group getting artificial sweeteners developed marked intolerance to glucose.
Glucose intolerance, in which the body is less able to cope with large amounts of sugar, can lead to more serious illnesses like metabolic syndrome and Type 2 diabetes.
When the researchers treated the mice with antibiotics, killing much of the bacteria in the digestive system, the glucose intolerance went away.
...
More 
Deeper
Original Article


Thursday, September 18, 2014

Fighting Poisons With Bacteria

Going Inside the Rice Microbiome


When Harsh Bais grows rice plants in trays of water in his greenhouse at the University of Delaware, he can easily spot the ones that have been exposed to arsenic: They are stunted, with shorter stems and shrunken, yellow-tinged leaves.
Dr. Bais is working to develop rice plants that take up less arsenic, a common contaminant in the fields of his native India and other Asian countries. Chronic exposure to arsenic has been linked to heart disease, diabetes and genetic damage associated with elevated risk for cancer.
But instead of trying to breed new strains of rice or alter its DNA, he and other scientists have set out in a surprising new direction. They are looking at the vast and untapped microbial community that lives near the rice’s roots.
These bacteria are the botanic equivalent of the human microbiome — the trillions of organisms that live in our guts, many performing beneficial tasks like digesting food and fighting off infection.
The hope is to find bacteria that will somehow block arsenic in its path from soil to roots to stem to edible grain. In the past three years, Dr. Bais has isolated about a dozen bacterial species, added them to plants in the greenhouse and looked for the telltale signs of arsenic poisoning.
Now, he says, he has zeroed in on one species, Pantoea agglomerans, that seems to reduce arsenic in the plant’s stem to one-eighth its former levels.

More

Found by Katie